ロード中...
Interleukin-22, a potent target for treatment of non-autoimmune diseases
Interleukin −22 (IL-22) is a member of interleukin-10 (IL-10) family cytokines that is produced by different types of lymphocytes included in both innate and adaptive immune systems. These lymphocytes include activated T cells, most notably Th17 and Th22 cells, as well as NK cells, γδ T cells, etc....
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343613/ https://ncbi.nlm.nih.gov/pubmed/30335564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1509649 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|